TruScreen Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Stock Symbol
  • TRU

Stock Symbol

TruScreen General Information

Description

Truscreen Group Ltd is a medical device company that has developed an AI-enabled device that can detect precancerous and cancerous cervical changes in real-time via optical and electrical measurements of cervical tissue. The company develops, manufactures, and sells cancer detection devices and systems. Its products include The TrueScreen device and HPV Test kits. It operates in one operating segment. It owns the rights to the TruScreen Cervical Cancer screening device, which comprises a medical device and process designed to detect the presence in real time of precancerous and cancerous tissue on the cervix. Geographically, it operates in Mexico, China, Central Asia, Vietnam, Zimbabwe, Indonesia, India, and MENA (Middle East/North Africa), with the majority of revenue deriving from China.

Contact Information

Website
www.truscreen.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • C HBL Mann Judd Limited, Level 6, Equitable House
  • 57 Symonds Street
  • Auckland, 1010
  • New Zealand
+64 09
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Stock Exchange
NZE
Vertical(s)
Manufacturing, Life Sciences, Oncology
Corporate Office
  • C HBL Mann Judd Limited, Level 6, Equitable House
  • 57 Symonds Street
  • Auckland, 1010
  • New Zealand
+64 09

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TruScreen Stock Performance

As of 13-Nov-2026, TruScreen’s current market cap is $4.65M with 1.05B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.65M 1.05B 764K

TruScreen Financials Summary

As of 31-Mar-2026, TruScreen has a trailing 12-month revenue of $1.43M.

In Thousands,
USD 		TTM 31-Mar-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 7,234 7,234 8,719 6,797
Revenue 1,429 1,429 1,013 1,284
EBITDA (1,316) (1,316) (1,320) (1,251)
Net Income (1,322) (1,322) (1,327) (1,249)
Total Assets 2,143 2,143 1,055 2,404
Total Debt 115 115 181 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

TruScreen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore TruScreen‘s full profile, request access.

Request a free trial

TruScreen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Truscreen Group Ltd is a medical device company that has developed an AI-enabled device that can detect precancerous and
Diagnostic Equipment
Auckland, New Zealand

Carlton, Australia
 

Melbourne, Australia
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TruScreen Competitors (4)

One of TruScreen’s 4 competitors is 4DMedical, a Formerly VC-backed company based in Carlton, Australia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
4DMedical Formerly VC-backed Carlton, Australia
Adherium Formerly VC-backed Melbourne, Australia
NIOX Group Formerly VC-backed Oxford, United Kingdom
Amiko Venture Capital-Backed Milan, Italy
To view TruScreen’s complete competitors history, request access »

Ready to get started?

Request a free trial

TruScreen ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view TruScreen’s complete esg history, request access »

TruScreen FAQs

  • When was TruScreen founded?

    TruScreen was founded in 2013.

  • Where is TruScreen headquartered?

    TruScreen is headquartered in Auckland, New Zealand.

  • What industry is TruScreen in?

    TruScreen’s primary industry is Diagnostic Equipment.

  • Is TruScreen a private or public company?

    TruScreen is a Public company.

  • What is TruScreen’s stock symbol?

    The ticker symbol for TruScreen is TRU.

  • What is the current market cap of TruScreen?

    The current market capitalization of TruScreen is $4.65M.

  • What is TruScreen’s current revenue?

    The trailing twelve month revenue for TruScreen is $1.43M.

  • Who are TruScreen’s competitors?

    4DMedical, Adherium, NIOX Group, and Amiko are competitors of TruScreen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process